Skip to main content
Top
Published in: World Journal of Surgery 2/2020

Open Access 01-02-2020 | Metastasis | Original Scientific Report

Invasiveness and Metastatic Aggressiveness in Small Differentiated Thyroid Cancers: Demography of Small Papillary Thyroid Carcinomas in the Swedish Population

Authors: Haytham Bayadsi, Martin Bergman, Malin Sund, Joakim Hennings

Published in: World Journal of Surgery | Issue 2/2020

Login to get access

Abstract

Background

The western world is seeing a rising incidence of thyroid cancer. Improved diagnostic methods do not entirely explain this increase. Papillary thyroid carcinoma (PTC) is the most common subtype of thyroid cancer. Small PTC (≤20 mm) and especially papillary thyroid microcarcinomas (PTMC ≤10 mm) are considered to be low-risk tumors but some cases are considerably more aggressive. Sufficient understanding of these mechanisms is a long-term goal for more efficient and safer treatment of these tumors.

Methods

We identified 959 cases of small PTCs in the validated Scandinavian Quality Register for Thyroid, Parathyroid and Adrenal Surgery, grouped according to lymph node metastasis. These were analyzed according to age, gender, tumor size and geographic region.

Results

Patients with N1b disease (lateral lymph nodes metastases) had a smaller tumor size compared to patients with N1a disease (8.6 mm vs 10.1 mm respectively, p < 0.05). Patients and specifically females with N1b disease were younger than those with N0 or N1a disease. Patients with N1b disease had a lower proportion of females (60%) compared to N0 and N1a groups (81% and 78%, respectively). The incidence of operated small PTCs and of lymph node engagement differs between geographic regions in Sweden.

Conclusions

Small PTC and especially PTMC seem to show different patterns of aggressiveness and demography regarding lateral lymph node metastases and 7% had N1b disease and tumor <1 cm, underscoring the importance of lymph node evaluation in PTMC patients. More understanding of predictive factors, mechanisms for metastatic disease and causes of regional differences, is needed.
Appendix
Available only for authorised users
Literature
1.
go back to reference SQRTPA Scandinavian Quality Register for Thyroid, Parathyriod and Adrenal Surgery—Annual Report 2018 (2018). www.sqrtpa.se. Accessed Jan 2019 SQRTPA Scandinavian Quality Register for Thyroid, Parathyriod and Adrenal Surgery—Annual Report 2018 (2018). www.​sqrtpa.​se. Accessed Jan 2019
3.
go back to reference Lundgren CI, Hall P, Ekbom A et al (2003) Incidence and survival of Swedish patients with differentiated thyroid cancer. Int J Cancer 106:569–573CrossRef Lundgren CI, Hall P, Ekbom A et al (2003) Incidence and survival of Swedish patients with differentiated thyroid cancer. Int J Cancer 106:569–573CrossRef
4.
go back to reference Links TP, van Tol KM, Jager PL et al (2005) Life expectancy in differentiated thyroid cancer: a novel approach to survival analysis. Endocr Relat Cancer 12:273–280CrossRef Links TP, van Tol KM, Jager PL et al (2005) Life expectancy in differentiated thyroid cancer: a novel approach to survival analysis. Endocr Relat Cancer 12:273–280CrossRef
5.
go back to reference ATAG Taskforce on Thyroid Nodules, Differentiated Thyroid Cancer, Cooper CS et al (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167–1214CrossRef ATAG Taskforce on Thyroid Nodules, Differentiated Thyroid Cancer, Cooper CS et al (2009) Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167–1214CrossRef
7.
go back to reference Pellegriti G, Scollo C, Lumera G et al (2004) Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: a study of 299 cases. J Clin Endocrinol Metab 89:3713–3720CrossRef Pellegriti G, Scollo C, Lumera G et al (2004) Clinical behavior and outcome of papillary thyroid cancers smaller than 1.5 cm in diameter: a study of 299 cases. J Clin Endocrinol Metab 89:3713–3720CrossRef
8.
go back to reference Siegel RL, Miller KD, Jemal A (2019) Cancer statistics, 2019. CA Cancer J Clin 69:7–34CrossRef Siegel RL, Miller KD, Jemal A (2019) Cancer statistics, 2019. CA Cancer J Clin 69:7–34CrossRef
9.
go back to reference Roman BR, Morris LG, Davies L (2017) The thyroid cancer epidemic, 2017 perspective. Curr Opin Endocrinol Diabetes Obes 24:332–336CrossRef Roman BR, Morris LG, Davies L (2017) The thyroid cancer epidemic, 2017 perspective. Curr Opin Endocrinol Diabetes Obes 24:332–336CrossRef
10.
go back to reference Vaccarella S, Franceschi S, Bray F et al (2016) Worldwide thyroid cancer epidemic? The increasing impact of overdiagnosis. N Engl J Med 375:614–617CrossRef Vaccarella S, Franceschi S, Bray F et al (2016) Worldwide thyroid cancer epidemic? The increasing impact of overdiagnosis. N Engl J Med 375:614–617CrossRef
11.
go back to reference Nikiforov YE (2010) Is ionizing radiation responsible for the increasing incidence of thyroid cancer? Cancer 116:1626–1628CrossRef Nikiforov YE (2010) Is ionizing radiation responsible for the increasing incidence of thyroid cancer? Cancer 116:1626–1628CrossRef
12.
go back to reference Marques P, Leite V, Bugalho MJ (2014) Retrospective analysis of 255 papillary thyroid carcinomas ≤2 cm: clinicohistological features and prognostic factors. Eur Thyroid J 3:258–263CrossRef Marques P, Leite V, Bugalho MJ (2014) Retrospective analysis of 255 papillary thyroid carcinomas ≤2 cm: clinicohistological features and prognostic factors. Eur Thyroid J 3:258–263CrossRef
13.
go back to reference Freni F, Galletti B, Galletti F et al (2018) Improved outcomes for papillary thyroid microcarcinoma care: active surveillance and case volume. Ther Adv Endocrinol Metab 9:185–186CrossRef Freni F, Galletti B, Galletti F et al (2018) Improved outcomes for papillary thyroid microcarcinoma care: active surveillance and case volume. Ther Adv Endocrinol Metab 9:185–186CrossRef
14.
go back to reference Lundgren CI, Hall P, Dickman PW et al (2006) Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study. Cancer 106:524–531CrossRef Lundgren CI, Hall P, Dickman PW et al (2006) Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study. Cancer 106:524–531CrossRef
15.
go back to reference Zhang X, Zhang L, Xue S et al (2019) Predictive factors of lateral lymph node metastasis in solitary papillary thyroid microcarcinoma without gross extrathyroidal extension. Asian J Surg 42(4):563–570CrossRef Zhang X, Zhang L, Xue S et al (2019) Predictive factors of lateral lymph node metastasis in solitary papillary thyroid microcarcinoma without gross extrathyroidal extension. Asian J Surg 42(4):563–570CrossRef
17.
go back to reference Moon JH, Kim JH, Lee EK et al (2018) Corrigendum: author's name correction. Study protocol of multicenter prospective cohort study of active surveillance on papillary thyroid microcarcinoma (MAeSTro). Endocrinol Metab (Seoul) 33:427CrossRef Moon JH, Kim JH, Lee EK et al (2018) Corrigendum: author's name correction. Study protocol of multicenter prospective cohort study of active surveillance on papillary thyroid microcarcinoma (MAeSTro). Endocrinol Metab (Seoul) 33:427CrossRef
19.
go back to reference AJCC (2009) AJCC 7th ed. cancer staging manual AJCC (2009) AJCC 7th ed. cancer staging manual
20.
go back to reference ACS Cancer Statistics Center—Thyroid, American Cancer Society (2019). ACS Cancer Statistics Center—Thyroid, American Cancer Society (2019).
21.
go back to reference Wang TS, Sosa JA (2018) Thyroid surgery for differentiated thyroid cancer - recent advances and future directions. Nat Rev Endocrinol 14:670–683CrossRef Wang TS, Sosa JA (2018) Thyroid surgery for differentiated thyroid cancer - recent advances and future directions. Nat Rev Endocrinol 14:670–683CrossRef
22.
go back to reference Gong Y, Yang J, Yan S et al (2018) Pattern of and clinicopathologic risk factors for lateral lymph node metastases in papillary thyroid carcinoma patients with lateral cervical lymphadenopathy. Medicine (Baltimore) 97(36):e12263CrossRef Gong Y, Yang J, Yan S et al (2018) Pattern of and clinicopathologic risk factors for lateral lymph node metastases in papillary thyroid carcinoma patients with lateral cervical lymphadenopathy. Medicine (Baltimore) 97(36):e12263CrossRef
Metadata
Title
Invasiveness and Metastatic Aggressiveness in Small Differentiated Thyroid Cancers: Demography of Small Papillary Thyroid Carcinomas in the Swedish Population
Authors
Haytham Bayadsi
Martin Bergman
Malin Sund
Joakim Hennings
Publication date
01-02-2020
Publisher
Springer International Publishing
Published in
World Journal of Surgery / Issue 2/2020
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-019-05312-4

Other articles of this Issue 2/2020

World Journal of Surgery 2/2020 Go to the issue